Ticagrelor induced systemic inflammatory response syndrome

@inproceedings{Krisai2017TicagrelorIS,
  title={Ticagrelor induced systemic inflammatory response syndrome},
  author={Philipp Krisai and Manuel Haschke and Peter Buser and Christian M{\"u}ller},
  booktitle={BMC cardiovascular disorders},
  year={2017}
}
BACKGROUND Ticagrelor is a reversible and direct-acting oral antagonist of the adenosine diphosphate receptor P2Y12. Possible adenosine-mediated effects of ticagrelor on inflammation are complex and incompletely understood. To our knowledge, ticagrelor-induced systemic inflammatory response syndrome (SIRS) has not yet been described. CASE PRESENTATION We… CONTINUE READING